Back to search
Non-progressive Congenital Ataxia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-progressive Congenital Ataxia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-progressive Congenital Ataxia trials you may qualify forThe Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1) is focused on gathering longitudinal clinical data as well as biological…
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
This multinational European observational clinical study focuses on non-progressive congenital ataxia (NPCA), a very rare early-onset neurological condition als…
Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple…
RATIONALE: Antifungals, such as caspofungin acetate, may be effective in treating fungal infections caused by chemotherapy or stem cell transplant. PURPOSE: Th…